€CEBL
Este fondo tiene como objetivo seguir el índice MSCI Emerging Markets Asia, que cubre empresas de mediana y gran capitalización de los mercados emergentes asiáticos.
Nombre | Peso | Capitalización | Precio | Variación diaria |
|---|---|---|---|---|
18,19 % | N/A | N/A | N/A | |
8,52 % | N/A | N/A | N/A | |
6,86 % | N/A | N/A | N/A | |
4,27 % | N/A | N/A | N/A | |
3,32 % | N/A | N/A | N/A | |
2,23 % | N/A | N/A | N/A | |
2,04 % | N/A | N/A | N/A | |
1,08 % | N/A | N/A | N/A | |
1,05 % | N/A | N/A | N/A | |
0,97 % | N/A | N/A | N/A | |
0,95 % | N/A | N/A | N/A | |
0,83 % | N/A | N/A | N/A | |
0,74 % | N/A | N/A | N/A | |
0,68 % | N/A | N/A | N/A | |
0,67 % | N/A | N/A | N/A | |
0,63 % | N/A | N/A | N/A | |
0,63 % | N/A | N/A | N/A | |
0,59 % | N/A | N/A | N/A | |
0,55 % | N/A | N/A | N/A | |
0,53 % | N/A | N/A | N/A | |
0,52 % | N/A | N/A | N/A | |
0,5 % | N/A | N/A | N/A | |
0,48 % | N/A | N/A | N/A | |
0,47 % | N/A | N/A | N/A | |
0,45 % | N/A | N/A | N/A | |
0,41 % | N/A | N/A | N/A | |
0,41 % | N/A | N/A | N/A | |
PDD $PDDOtrosProductos de primera necesidad | 0,4 % | - | ||
0,4 % | N/A | N/A | N/A | |
0,4 % | N/A | N/A | N/A | |
0,37 % | N/A | N/A | N/A | |
0,36 % | N/A | N/A | N/A | |
0,36 % | N/A | N/A | N/A | |
0,35 % | N/A | N/A | N/A | |
0,34 % | N/A | N/A | N/A | |
0,34 % | N/A | N/A | N/A | |
0,33 % | N/A | N/A | N/A | |
Infosys $INFYOtrosServicios empresariales | 0,33 % | - | ||
0,31 % | N/A | N/A | N/A | |
0,3 % | N/A | N/A | N/A | |
0,3 % | N/A | N/A | N/A | |
0,29 % | N/A | N/A | N/A | |
0,29 % | N/A | N/A | N/A | |
0,28 % | N/A | N/A | N/A | |
0,28 % | N/A | N/A | N/A | |
0,28 % | N/A | N/A | N/A | |
0,28 % | N/A | N/A | N/A | |
0,28 % | N/A | N/A | N/A | |
0,27 % | N/A | N/A | N/A | |
0,27 % | N/A | N/A | N/A | |
0,26 % | N/A | N/A | N/A | |
0,26 % | N/A | N/A | N/A | |
0,26 % | N/A | N/A | N/A | |
0,25 % | N/A | N/A | N/A | |
0,25 % | N/A | N/A | N/A | |
0,24 % | N/A | N/A | N/A | |
0,24 % | N/A | N/A | N/A | |
0,24 % | N/A | N/A | N/A | |
0,23 % | N/A | N/A | N/A | |
0,23 % | N/A | N/A | N/A | |
0,23 % | N/A | N/A | N/A | |
0,22 % | N/A | N/A | N/A | |
0,21 % | N/A | N/A | N/A | |
0,21 % | N/A | N/A | N/A | |
0,21 % | N/A | N/A | N/A | |
0,21 % | N/A | N/A | N/A | |
0,21 % | N/A | N/A | N/A | |
BeOne Medicines AG $ONCOtrosSalud | 0,21 % | - | ||
0,21 % | N/A | N/A | N/A | |
0,21 % | N/A | N/A | N/A | |
0,2 % | N/A | N/A | N/A | |
0,19 % | N/A | N/A | N/A | |
0,19 % | N/A | N/A | N/A | |
0,19 % | N/A | N/A | N/A | |
0,19 % | N/A | N/A | N/A | |
0,19 % | N/A | N/A | N/A | |
0,19 % | N/A | N/A | N/A | |
0,19 % | N/A | N/A | N/A | |
0,19 % | N/A | N/A | N/A | |
0,18 % | N/A | N/A | N/A | |
0,18 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,17 % | N/A | N/A | N/A | |
0,16 % | N/A | N/A | N/A | |
0,16 % | N/A | N/A | N/A | |
0,16 % | N/A | N/A | N/A | |
0,16 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,15 % | N/A | N/A | N/A | |
0,14 % | N/A | N/A | N/A | |
0,14 % | N/A | N/A | N/A | |
0,14 % | N/A | N/A | N/A | |
0,14 % | N/A | N/A | N/A | |
0,14 % | N/A | N/A | N/A | |
0,14 % | N/A | N/A | N/A | |
0,13 % | N/A | N/A | N/A | |
0,13 % | N/A | N/A | N/A | |
0,13 % | N/A | N/A | N/A | |
0,13 % | N/A | N/A | N/A | |
0,13 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,12 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,11 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,1 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,09 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
H World Group $HTHTOtrosConsumo discrecional | 0,08 % | - | ||
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,08 % | N/A | N/A | N/A | |
0,07 % | N/A | N/A | N/A |